Sisram Medical (HKSE:01696) 3-Year EBITDA Growth Rate : 21.70% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical 3-Year EBITDA Growth Rate?

Sisram Medical's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.29.

During the past 12 months, Sisram Medical's average EBITDA Per Share Growth Rate was -8.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sisram Medical was 22.60% per year. The lowest was -12.60% per year. And the median was 16.10% per year.

Competitive Comparison of Sisram Medical's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Sisram Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sisram Medical's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sisram Medical's 3-Year EBITDA Growth Rate falls into.

Sisram Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sisram Medical (HKSE:01696) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sisram Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sisram Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sisram Medical (HKSE:01696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895

Website

https://www.sisram-medical.com

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Executives

Fosun Holdings Limited
Fosun International Holdings Ltd.
Fosun International Limited
Guo Guangchang
Ample Up Limited
Fosun Industrial Co., Limited
Shanghai Fosun High Technology (group) Co., Ltd.
Shanghai Fosun Pharmaceutical (group) Co., Ltd.
Chindex Medical Limited

Sisram Medical (HKSE:01696) Headlines

No Headlines